{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:13:47Z","timestamp":1783440827267,"version":"3.54.6"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00467-020-04790-2","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T06:02:47Z","timestamp":1602741767000},"page":"2279-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Malignancies after pediatric solid organ transplantation"],"prefix":"10.1007","volume":"36","author":[{"given":"Cal","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-5046","authenticated-orcid":false,"given":"Abhijat","family":"Kitchlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"4790_CR1","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","volume":"80","author":"JF Buell","year":"2005","unstructured":"Buell JF, Gross TG, Woodle ES (2005) Malignancy after transplantation. Transplantation 80:S254\u2013S264. https:\/\/doi.org\/10.1097\/01.tp.0000186382.81130.ba","journal-title":"Transplantation"},{"key":"4790_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/petr.12166","volume":"17","author":"JM Smith","year":"2013","unstructured":"Smith JM, Martz K, McDonald RA, Harmon WE (2013) Solid tumors following kidney transplantation in children. Pediatr Transplant 17:726\u2013730. https:\/\/doi.org\/10.1111\/petr.12166","journal-title":"Pediatr Transplant"},{"key":"4790_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ajt.13978","volume":"17","author":"SA Acuna","year":"2017","unstructured":"Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C, Kim SJ, Baxter NN (2017) Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 17:103\u2013114. https:\/\/doi.org\/10.1111\/ajt.13978","journal-title":"Am J Transplant"},{"key":"4790_CR4","doi-asserted-by":"publisher","first-page":"e20163893","DOI":"10.1542\/peds.2016-3893","volume":"139","author":"EL Yanik","year":"2017","unstructured":"Yanik EL, Smith JM, Shiels MS, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA (2017) Cancer risk after pediatric solid organ transplantation. Pediatrics 139:e20163893. https:\/\/doi.org\/10.1542\/peds.2016-3893","journal-title":"Pediatrics"},{"key":"4790_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1600-6143.2010.03367.x","volume":"11","author":"JF Simard","year":"2011","unstructured":"Simard JF, Baecklund E, Kinch A, Brattstr\u00f6m C, Ingvar A, Molin D, Adami J, Fernberg P, Wilczek H, Ekbom A, Smedby KE (2011) Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden: pediatric transplantation and risk of tumors. Am J Transplant 11:146\u2013151. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03367.x","journal-title":"Am J Transplant"},{"key":"4790_CR6","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1111\/ajt.14289","volume":"17","author":"A Francis","year":"2017","unstructured":"Francis A, Johnson DW, Craig JC, Wong G (2017) Incidence and predictors of cancer following kidney transplantation in childhood. Am J Transplant 17:2650\u20132658. https:\/\/doi.org\/10.1111\/ajt.14289","journal-title":"Am J Transplant"},{"key":"4790_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/TP.0000000000002378","volume":"103","author":"A Kitchlu","year":"2019","unstructured":"Kitchlu A, Dixon S, Dirk JS, Chanchlani R, Vasilevska-Ristovska J, Borges K, Dipchand AI, Ng VL, Hebert D, Solomon M, Michael Paterson J, Gupta S, Joseph Kim S, Nathan PC, Parekh RS (2019) Elevated risk of cancer after solid organ transplant in childhood: a population-based cohort study. Transplantation 103:588\u2013596. https:\/\/doi.org\/10.1097\/TP.0000000000002378","journal-title":"Transplantation"},{"key":"4790_CR8","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.2215\/CJN.03630415","volume":"10","author":"S Ploos van Amstel","year":"2015","unstructured":"Ploos van Amstel S, Vogelzang JL, Starink MV, Jager KJ, Groothoff JW (2015) Long-term risk of cancer in survivors of pediatric ESRD. Clin J Am Soc Nephrol 10:2198\u20132204. https:\/\/doi.org\/10.2215\/CJN.03630415","journal-title":"Clin J Am Soc Nephrol"},{"key":"4790_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s10350-004-0674-0","volume":"47","author":"HT Papaconstantinou","year":"2004","unstructured":"Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J, Alloway RR, Woodle ES, Buell JF (2004) Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum 47:1898\u20131903. https:\/\/doi.org\/10.1007\/s10350-004-0674-0","journal-title":"Dis Colon Rectum"},{"key":"4790_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","volume":"2","author":"SA Acuna","year":"2016","unstructured":"Acuna SA, Fernandes KA, Daly C, Hicks LK, Sutradhar R, Kim SJ, Baxter NN (2016) Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. JAMA Oncol 2:463\u2013469. https:\/\/doi.org\/10.1001\/jamaoncol.2015.5137","journal-title":"JAMA Oncol"},{"key":"4790_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(07)61050-2","journal-title":"Lancet"},{"key":"4790_CR12","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891\u20131901. https:\/\/doi.org\/10.1001\/jama.2011.1592","journal-title":"JAMA"},{"key":"4790_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","volume":"89","author":"J Adami","year":"2003","unstructured":"Adami J, G\u00e4bel H, Lindel\u00f6f B, Ekstr\u00f6m K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89:1221\u20131227. https:\/\/doi.org\/10.1038\/sj.bjc.6601219","journal-title":"Br J Cancer"},{"key":"4790_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamcollsurg.2017.04.012","volume":"225","author":"OK Serrano","year":"2017","unstructured":"Serrano OK, Bangdiwala AS, Vock DM, Chinnakotla S, Dunn TB, Finger EB, Kandaswamy R, Pruett TL, Najarian JS, Matas AJ, Chavers BM (2017) Post-transplant malignancy after pediatric kidney transplantation: retrospective analysis of incidence and risk factors in 884 patients receiving transplants between 1963 and 2015 at the University of Minnesota. J Am Coll Surg 225:181\u2013193. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.04.012","journal-title":"J Am Coll Surg"},{"key":"4790_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ndt\/gfp497","volume":"25","author":"F Koukourgianni","year":"2010","unstructured":"Koukourgianni F, Harambat J, Ranchin B, Euvrard S, Bouvier R, Liutkus A, Cochat P (2010) Malignancy incidence after renal transplantation in children: a 20-year single-centre experience. Nephrol Dial Transplant 25:611\u2013616. https:\/\/doi.org\/10.1093\/ndt\/gfp497","journal-title":"Nephrol Dial Transplant"},{"key":"4790_CR16","first-page":"56","volume":"2","author":"I Penn","year":"1998","unstructured":"Penn I (1998) De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 2:56\u201363","journal-title":"Pediatr Transplant"},{"key":"4790_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.sempedsurg.2006.03.005","volume":"15","author":"JF Buell","year":"2006","unstructured":"Buell JF, Gross TG, Thomas MJ, Neff G, Muthiah C, Alloway R, Ryckman FC, Tiao GM, Woodle ES (2006) Malignancy in pediatric transplant recipients. Semin Pediatr Surg 15:179\u2013187. https:\/\/doi.org\/10.1053\/j.sempedsurg.2006.03.005","journal-title":"Semin Pediatr Surg"},{"key":"4790_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","volume":"3","author":"SM Cockfield","year":"2001","unstructured":"Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3:70\u201378. https:\/\/doi.org\/10.1034\/j.1399-3062.2001.003002070.x","journal-title":"Transpl Infect Dis"},{"key":"4790_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/TP.0b013e3181f30479","volume":"90","author":"FP Hurst","year":"2010","unstructured":"Hurst FP, Jindal RM, Graham LJ, Falta EM, Elster EA, Stackhouse GB, Agodoa LY, Lentine KL, Salifu MO, Abbott KC (2010) Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation 90:898\u2013904. https:\/\/doi.org\/10.1097\/TP.0b013e3181f30479","journal-title":"Transplantation"},{"key":"4790_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"W-H Chow","year":"2010","unstructured":"Chow W-H, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245\u2013257. https:\/\/doi.org\/10.1038\/nrurol.2010.46","journal-title":"Nat Rev Urol"},{"key":"4790_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/ajt.14603","volume":"18","author":"VR Dharnidharka","year":"2018","unstructured":"Dharnidharka VR (2018) Comprehensive review of post-organ transplant hematologic cancers. Am J Transplant 18:537\u2013549. https:\/\/doi.org\/10.1111\/ajt.14603","journal-title":"Am J Transplant"},{"key":"4790_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jpeds.2019.04.017","volume":"211","author":"JT Huang","year":"2019","unstructured":"Huang JT, Coughlin CC, Hawryluk EB, Hook K, Humphrey SR, Kruse L, Lawley L, Al-Sayegh H, London WB, Marghoob A, Phung TL, Pope E, Gerami P, Schmidt B, Robinson S, Bartenstein D, Bahrani E, Brahmbhatt M, Chen L, Haddock E, Mansour D, Nguyen J, Raisanen T, Tran G, Travis K, Wolner Z, Eichenfield LF (2019) Risk factors and outcomes of nonmelanoma skin cancer in children and young adults. J Pediatr 211:152\u2013158. https:\/\/doi.org\/10.1016\/j.jpeds.2019.04.017","journal-title":"J Pediatr"},{"key":"4790_CR23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"Suppl 3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant Suppl 3:S1\u2013S155. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x","journal-title":"Am J Transplant"},{"key":"4790_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","volume":"80","author":"S Caillard","year":"2005","unstructured":"Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233\u20131243. https:\/\/doi.org\/10.1097\/01.tp.0000179639.98338.39","journal-title":"Transplantation"},{"key":"4790_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, D\u00f6hler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4:222\u2013230. https:\/\/doi.org\/10.1046\/j.1600-6143.2003.00325.x","journal-title":"Am J Transplant"},{"key":"4790_CR26","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","volume":"7","author":"AD Kirk","year":"2007","unstructured":"Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM (2007) dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant 7:2619\u20132625. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01972.x","journal-title":"Am J Transplant"},{"key":"4790_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/TP.0000000000000449","volume":"99","author":"EC Hall","year":"2015","unstructured":"Hall EC, Engels EA, Pfeiffer RM, Segev DL (2015) Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation 99:1051\u20131057. https:\/\/doi.org\/10.1097\/TP.0000000000000449","journal-title":"Transplantation"},{"key":"4790_CR28","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","volume":"63","author":"TM Chapman","year":"2003","unstructured":"Chapman TM, Keating GM (2003) Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs 63:2803\u20132835. https:\/\/doi.org\/10.2165\/00003495-200363240-00009","journal-title":"Drugs"},{"key":"4790_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/tri.12850","volume":"29","author":"VR Dharnidharka","year":"2016","unstructured":"Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL (2016) Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study. Transpl Int 29:1226\u20131236. https:\/\/doi.org\/10.1111\/tri.12850","journal-title":"Transpl Int"},{"key":"4790_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/ajt.12104","volume":"13","author":"UD Allen","year":"2013","unstructured":"Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice (2013) Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation: EBV and PTLD. Am J Transplant 13:107\u2013120. https:\/\/doi.org\/10.1111\/ajt.12104","journal-title":"Am J Transplant"},{"key":"4790_CR31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/01.tp.0000120181.89206.54","volume":"77","author":"M Guba","year":"2004","unstructured":"Guba M, Graeb C, Jauch K-W, Geissler EK (2004) Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77:1777\u20131782. https:\/\/doi.org\/10.1097\/01.tp.0000120181.89206.54","journal-title":"Transplantation"},{"key":"4790_CR32","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","volume":"5","author":"R Robson","year":"2005","unstructured":"Robson R, Cecka JM, Opelz G, Budde M, Sacks S (2005) Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant 5:2954\u20132960. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01125.x","journal-title":"Am J Transplant"},{"key":"4790_CR33","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","volume":"16","author":"Z Jiyad","year":"2016","unstructured":"Jiyad Z, Olsen CM, Burke MT, Isbel NM, Green AC (2016) Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant 16:3490\u20133503. https:\/\/doi.org\/10.1111\/ajt.13863","journal-title":"Am J Transplant"},{"key":"4790_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","volume":"37","author":"M Vos","year":"2018","unstructured":"Vos M, Plasmeijer EI, van Bemmel BC, van der Bij W, Klaver NS, Erasmus ME, de Bock GH, Verschuuren EAM, R\u00e1cz E (2018) Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation. J Heart Lung Transplant 37:853\u2013859. https:\/\/doi.org\/10.1016\/j.healun.2018.03.012","journal-title":"J Heart Lung Transplant"},{"key":"4790_CR35","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/cncr.22636","volume":"109","author":"T Imao","year":"2007","unstructured":"Imao T, Ichimaru N, Takahara S, Kokado Y, Okumi M, Imamura R, Namba Y, Isaka Y, Nonomura N, Okuyama A (2007) Risk factors for malignancy in Japanese renal transplant recipients. Cancer 109:2109\u20132115. https:\/\/doi.org\/10.1002\/cncr.22636","journal-title":"Cancer"},{"key":"4790_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/ckj\/sfx122","volume":"11","author":"B Sprangers","year":"2018","unstructured":"Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD (2018) Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Clin Kidney J 11:315\u2013329. https:\/\/doi.org\/10.1093\/ckj\/sfx122","journal-title":"Clin Kidney J"},{"key":"4790_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/17401","volume":"397","author":"M Hojo","year":"1999","unstructured":"Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530\u2013534. https:\/\/doi.org\/10.1038\/17401","journal-title":"Nature"},{"key":"4790_CR38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","volume":"76","author":"M Maluccio","year":"2003","unstructured":"Maluccio M, Sharma V, Lagman M, Vyas S, Yang H, Li B, Suthanthiran M (2003) Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation 76:597\u2013602. https:\/\/doi.org\/10.1097\/01.TP.0000081399.75231.3B","journal-title":"Transplantation"},{"key":"4790_CR39","doi-asserted-by":"publisher","first-page":"g6679","DOI":"10.1136\/bmj.g6679","volume":"349","author":"GA Knoll","year":"2014","unstructured":"Knoll GA, Kokolo MB, Mallick R, Beck A, Buenaventura CD, Ducharme R, Barsoum R, Bernasconi C, Blydt-Hansen TD, Ekberg H, Felipe CR, Firth J, Gallon L, Gelens M, Glotz D, Gossmann J, Guba M, Morsy AA, Salgo R, Scheuermann EH, Tedesco-Silva H, Vitko S, Watson C, Fergusson DA (2014) Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ 349:g6679. https:\/\/doi.org\/10.1136\/bmj.g6679","journal-title":"BMJ"},{"key":"4790_CR40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1432-2277.2012.01521.x","volume":"25","author":"C Courivaud","year":"2012","unstructured":"Courivaud C, Bamoulid J, Gaugler B, Roubiou C, Arregui C, Chalopin JM, Borg C, Tiberghien P, Woronoff-Lemsi MC, Saas P, Ducloux D (2012) Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients. Transpl Int 25:948\u2013955. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01521.x","journal-title":"Transpl Int"},{"key":"4790_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/030089160609200306","volume":"92","author":"GL Adani","year":"2006","unstructured":"Adani GL, Baccarani U, Lorenzin D, Bresadola V, Curr\u00f2 G, Sainz M, Gropuzzo M, Montanaro D, Tulissi P, Risaliti A, Bresadola F (2006) Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation. Tumori 92:219\u2013221","journal-title":"Tumori"},{"key":"4790_CR42","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1097\/TP.0000000000000641","volume":"99","author":"R Desai","year":"2015","unstructured":"Desai R, Collett D, Watson CJ, Johnson PJ, Moss P, Neuberger J (2015) Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation. Transplantation 99:1989\u20131994. https:\/\/doi.org\/10.1097\/TP.0000000000000641","journal-title":"Transplantation"},{"key":"4790_CR43","doi-asserted-by":"publisher","unstructured":"Wong G, Chakera A, Chapman JR, Chadban SC, Pilmore H, Craig JC, Lim WH (2017) Cytomegalovirus and cancer after kidney transplantation: role of the human leukocyte antigen system? Transpl Infect Dis 19(1). https:\/\/doi.org\/10.1111\/tid.12631","DOI":"10.1111\/tid.12631"},{"key":"4790_CR44","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/s0140-6736(05)80084-4","volume":"342","author":"G Opelz","year":"1993","unstructured":"Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514\u20131516. https:\/\/doi.org\/10.1016\/s0140-6736(05)80084-4","journal-title":"Lancet"},{"key":"4790_CR45","doi-asserted-by":"publisher","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","volume":"2","author":"VR Dharnidharka","year":"2016","unstructured":"Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S (2016) Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers 2:15088. https:\/\/doi.org\/10.1038\/nrdp.2015.88","journal-title":"Nat Rev Dis Primers"},{"key":"4790_CR46","doi-asserted-by":"publisher","first-page":"e13652","DOI":"10.1111\/ctr.13652","volume":"33","author":"UD Allen","year":"2019","unstructured":"Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice (2019) Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl 33:e13652. https:\/\/doi.org\/10.1111\/ctr.13652","journal-title":"Clin Transpl"},{"key":"4790_CR47","doi-asserted-by":"publisher","first-page":"150835","DOI":"10.1155\/2013\/150835","volume":"2013","author":"J Morscio","year":"2013","unstructured":"Morscio J, Dierickx D, Tousseyn T (2013) Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? Clin Dev Immunol 2013:150835. https:\/\/doi.org\/10.1155\/2013\/150835","journal-title":"Clin Dev Immunol"},{"key":"4790_CR48","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1111\/j.1537-2995.2012.03611.x","volume":"52","author":"H Trottier","year":"2012","unstructured":"Trottier H, Buteau C, Robitaille N, Duval M, Tucci M, Lacroix J, Alfieri C (2012) Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children. Transfusion (Paris) 52:2653\u20132663. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03611.x","journal-title":"Transfusion (Paris)"},{"key":"4790_CR49","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aiello A (2013) Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One 8:e64921. https:\/\/doi.org\/10.1371\/journal.pone.0064921","journal-title":"PLoS One"},{"key":"4790_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pbiomolbio.2011.08.010","volume":"107","author":"AC Green","year":"2011","unstructured":"Green AC, Wallingford SC, McBride P (2011) Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence. Prog Biophys Mol Biol 107:349\u2013355. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2011.08.010","journal-title":"Prog Biophys Mol Biol"},{"key":"4790_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/1096-9071(200007)61:3<289::aid-jmv2>3.0.co;2-z","volume":"61","author":"CA Harwood","year":"2000","unstructured":"Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61:289\u2013297. https:\/\/doi.org\/10.1002\/1096-9071(200007)61:3<289::aid-jmv2>3.0.co;2-z","journal-title":"J Med Virol"},{"key":"4790_CR52","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1600-6143.2011.03589.x","volume":"11","author":"CM Proby","year":"2011","unstructured":"Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN, EPI-HPV-UV-CA group (2011) A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients: betapapillomavirus and transplant skin cancers. Am J Transplant 11:1498\u20131508. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03589.x","journal-title":"Am J Transplant"},{"key":"4790_CR53","doi-asserted-by":"publisher","first-page":"e01003","DOI":"10.1128\/JVI.01003-18","volume":"93","author":"DE Rollison","year":"2019","unstructured":"Rollison DE, Viarisio D, Amorrortu RP, Gheit T, Tommasino M (2019) An emerging issue in oncogenic virology: the role of beta human papillomavirus types in the development of cutaneous squamous cell carcinoma. J Virol 93:e01003\u2013e01018. https:\/\/doi.org\/10.1128\/JVI.01003-18","journal-title":"J Virol"},{"key":"4790_CR54","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/tri.13493","volume":"32","author":"A Jambusaria-Pahlajani","year":"2019","unstructured":"Jambusaria-Pahlajani A, Crow LD, Lowenstein S, Garrett GL, Melcher ML, Chan AW, Boscardin J, Arron ST (2019) Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study. Transpl Int 32:1259\u20131267. https:\/\/doi.org\/10.1111\/tri.13493","journal-title":"Transpl Int"},{"key":"4790_CR55","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","volume":"61","author":"MD Denton","year":"2002","unstructured":"Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB, Cosimi AB, Tolkoff-Rubin N (2002) Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 61:2201\u20132209. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00374.x","journal-title":"Kidney Int"},{"key":"4790_CR56","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.healun.2006.09.009","volume":"25","author":"RP Dickson","year":"2006","unstructured":"Dickson RP, Davis RD, Rea JB, Palmer SM (2006) High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 25:1297\u20131301. https:\/\/doi.org\/10.1016\/j.healun.2006.09.009","journal-title":"J Heart Lung Transplant"},{"key":"4790_CR57","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/MCG.0b013e31825c0b3a","volume":"46","author":"JM Park","year":"2012","unstructured":"Park JM, Choi M-G, Yang CW, Jung CK, Lee SK, Yoon AR, Kim YS, Chung IS (2012) Increased incidence of gastric cancer in renal transplant recipients. J Clin Gastroenterol 46:e87\u2013e91. https:\/\/doi.org\/10.1097\/MCG.0b013e31825c0b3a","journal-title":"J Clin Gastroenterol"},{"key":"4790_CR58","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1148\/rg.2016150175","volume":"36","author":"VS Katabathina","year":"2016","unstructured":"Katabathina VS, Menias CO, Tammisetti VS, Lubner MG, Kielar A, Shaaban A, Mansour J, Surabhi VR, Hara AK (2016) Malignancy after solid organ transplantation: comprehensive imaging review. Radiographics 36:1390\u20131407. https:\/\/doi.org\/10.1148\/rg.2016150175","journal-title":"Radiographics"},{"key":"4790_CR59","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"4790_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","volume":"149","author":"A Parker","year":"2010","unstructured":"Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C, Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society (2010) Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol 149:693\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08160.x","journal-title":"Br J Haematol"},{"key":"4790_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ndt\/17.suppl_4.31","volume":"17 Suppl 4","author":"EBPG Expert Group on Renal Transplantation","year":"2002","unstructured":"EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrol Dial Transplant 17 Suppl 4:31\u201333, 35\u201336. https:\/\/doi.org\/10.1093\/ndt\/17.suppl_4.31","journal-title":"Nephrol Dial Transplant"},{"key":"4790_CR62","unstructured":"EBV Work Group, Cincinnati Children\u2019s Hospital Medical Center (2011) Evidence-based clinical care guideline for management of EBV-associated posttransplant lymphoproliferative disease in solid organ transplant. Cincinnatti Children\u2019s Hospital"},{"key":"4790_CR63","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","volume":"11","author":"R Reshef","year":"2011","unstructured":"Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Hadjiliadis D, Goral S, Krok KL, Goldberg LR, Porter DL, Stadtmauer EA, Tsai DE (2011) Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder\u2605: reduction of immunosuppression for PTLD. Am J Transplant 11:336\u2013347. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03387.x","journal-title":"Am J Transplant"},{"key":"4790_CR64","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","volume":"35","author":"RU Trappe","year":"2017","unstructured":"Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, D\u00fchrsen U, Reinke P, Verhoef G, Subklewe M, H\u00fcttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S (2017) Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial. J Clin Oncol 35:536\u2013543. https:\/\/doi.org\/10.1200\/JCO.2016.69.3564","journal-title":"J Clin Oncol"},{"key":"4790_CR65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1600-6143.2011.03470.x","volume":"11","author":"VR Dharnidharka","year":"2011","unstructured":"Dharnidharka VR, Martz KL, Stablein DM, Benfield MR (2011) Improved survival with recent Post-Transplant Lymphoproliferative Disorder (PTLD) in children with kidney transplants. Am J Transplant 11:751\u2013758. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03470.x","journal-title":"Am J Transplant"},{"key":"4790_CR66","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","volume":"23","author":"TG Gross","year":"2005","unstructured":"Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC (2005) Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol 23:6481\u20136488. https:\/\/doi.org\/10.1200\/JCO.2005.08.074","journal-title":"J Clin Oncol"},{"key":"4790_CR67","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","volume":"12","author":"TG Gross","year":"2012","unstructured":"Gross TG, Orjuela MA, Perkins SL, Park JR, Lynch JC, Cairo MS, Smith LM, Hayashi RJ (2012) Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children\u2019s Oncology Group Report. Am J Transplant 12:3069\u20133075. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04206.x","journal-title":"Am J Transplant"},{"key":"4790_CR68","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1309\/N82C-TQ1J-0XEV-EFQB","volume":"121","author":"AA Castellano-Sanchez","year":"2004","unstructured":"Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246\u2013253. https:\/\/doi.org\/10.1309\/N82C-TQ1J-0XEV-EFQB","journal-title":"Am J Clin Pathol"},{"key":"4790_CR69","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI121127","volume":"130","author":"S Prockop","year":"2020","unstructured":"Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, Jakubowski A, Hanash AM, Kernan NA, Kobos R, Koehne G, Landau H, Ponce D, Spitzer B, Young JW, Behr G, Dunphy M, Haque S, Teruya-Feldstein J, Arcila M, Moung C, Hsu S, Hasan A, O\u2019Reilly RJ (2020) Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. J Clin Invest 130:733\u2013747. https:\/\/doi.org\/10.1172\/JCI121127","journal-title":"J Clin Invest"},{"key":"4790_CR70","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","volume":"31","author":"S Caillard","year":"2013","unstructured":"Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil-Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B (2013) Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol 31:1302\u20131309. https:\/\/doi.org\/10.1200\/JCO.2012.43.2344","journal-title":"J Clin Oncol"},{"key":"4790_CR71","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2133.2000.03703.x","volume":"143","author":"B Lindel\u00f6f","year":"2000","unstructured":"Lindel\u00f6f B, Sigurgeirsson B, G\u00e4bel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation: Skin cancer following organ transplantation. Br J Dermatol 143:513\u2013519. https:\/\/doi.org\/10.1111\/j.1365-2133.2000.03703.x","journal-title":"Br J Dermatol"},{"key":"4790_CR72","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1204166","volume":"367","author":"S Euvrard","year":"2012","unstructured":"Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J, TUMORAPA Study Group (2012) Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 367:329\u2013339. https:\/\/doi.org\/10.1056\/NEJMoa1204166","journal-title":"N Engl J Med"},{"key":"4790_CR73","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","volume":"12","author":"SB Campbell","year":"2012","unstructured":"Campbell SB, Walker R, Tai SS, Jiang Q, Russ GR (2012) Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer. Am J Transplant 12:1146\u20131156. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04004.x","journal-title":"Am J Transplant"},{"key":"4790_CR74","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2012.12.953","volume":"68","author":"KM Cordoro","year":"2013","unstructured":"Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M (2013) Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol 68:913\u2013925. https:\/\/doi.org\/10.1016\/j.jaad.2012.12.953","journal-title":"J Am Acad Dermatol"},{"key":"4790_CR75","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1600-6143.2010.03078.x","volume":"10","author":"FO Zwald","year":"2010","unstructured":"Zwald FO, Christenson LJ, Billingsley EM, Zeitouni NC, Ratner D, Bordeaux J, Patel MJ, Brown MD, Proby CM, Euvrard S, Otley CC, Stasko T, Melanoma Working Group of The International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Patients, Europe (2010) Melanoma in solid organ transplant recipients. Am J Transplant 10:1297\u20131304. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03078.x","journal-title":"Am J Transplant"},{"key":"4790_CR76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","volume":"7","author":"N Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, Lin H, Wong MK, Abdelrahim M, Gaber AO, Suarez-Almazor ME, Diab A (2019) Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7:106. https:\/\/doi.org\/10.1186\/s40425-019-0585-1","journal-title":"J Immunother Cancer"},{"key":"4790_CR77","doi-asserted-by":"publisher","unstructured":"Kittai AS, Oldham H, Cetnar J, Taylor M (2017) Immune checkpoint inhibitors in organ transplant patients. J Immunother 40:277\u2013281. https:\/\/doi.org\/10.1097\/CJI.0000000000000180","DOI":"10.1097\/CJI.0000000000000180"},{"key":"4790_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/CCO.0000000000000505","volume":"31","author":"P De Bruyn","year":"2019","unstructured":"De Bruyn P, Van Gestel D, Ost P, Kruse V, Brochez L, Van Vlierberghe H, Devresse A, Del Marmol V, Le Moine A, Aspeslagh S (2019) Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go? Curr Opin Oncol 31:54\u201364. https:\/\/doi.org\/10.1097\/CCO.0000000000000505","journal-title":"Curr Opin Oncol"},{"key":"4790_CR79","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.kint.2018.05.006","volume":"94","author":"AR Kitching","year":"2018","unstructured":"Kitching AR, Jaw J (2018) Chimeric antigen receptor T (CAR T) cells: another cancer therapy with potential applications in kidney disease and transplantation? Kidney Int 94:4\u20136. https:\/\/doi.org\/10.1016\/j.kint.2018.05.006","journal-title":"Kidney Int"},{"key":"4790_CR80","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2015.64.5929","volume":"34","author":"JN Brudno","year":"2016","unstructured":"Brudno JN, Somerville RPT, Shi V, Rose JJ, Halverson DC, Fowler DH, Gea-Banacloche JC, Pavletic SZ, Hickstein DD, Lu TL, Feldman SA, Iwamoto AT, Kurlander R, Maric I, Goy A, Hansen BG, Wilder JS, Blacklock-Schuver B, Hakim FT, Rosenberg SA, Gress RE, Kochenderfer JN (2016) Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease. J Clin Oncol 34:1112\u20131121. https:\/\/doi.org\/10.1200\/JCO.2015.64.5929","journal-title":"J Clin Oncol"},{"key":"4790_CR81","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ajt.14175","volume":"17","author":"F Noyan","year":"2017","unstructured":"Noyan F, Zimmermann K, Hardtke-Wolenski M, Knoefel A, Schulde E, Geffers R, Hust M, Huehn J, Galla M, Morgan M, Jokuszies A, Manns MP, Jaeckel E (2017) Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor. Am J Transplant 17:917\u2013930. https:\/\/doi.org\/10.1111\/ajt.14175","journal-title":"Am J Transplant"},{"key":"4790_CR82","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","volume":"104","author":"SJ Chadban","year":"2020","unstructured":"Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Knoll GA (2020) KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation 104:S11\u2013S103. https:\/\/doi.org\/10.1097\/TP.0000000000003136","journal-title":"Transplantation"},{"key":"4790_CR83","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","volume":"88","author":"L Rees","year":"2009","unstructured":"Rees L, Tizard EJ, Morgan AJ, Cubitt WD, Finerty S, Oyewole-Eletu TA, Owen K, Royed C, Stevens SJ, Shroff RC, Tanday MK, Wilson AD, Middeldorp JM, Amlot PL, Steven NM (2009) A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation. Transplantation 88:1025\u20131029. https:\/\/doi.org\/10.1097\/TP.0b013e3181b9d918","journal-title":"Transplantation"},{"key":"4790_CR84","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1432-2277.2012.01485.x","volume":"25","author":"B H\u00f6cker","year":"2012","unstructured":"H\u00f6cker B, B\u00f6hm S, Fickenscher H, K\u00fcsters U, Schnitzler P, Pohl M, John U, Kemper MJ, Fehrenbach H, Wigger M, Holder M, Schr\u00f6der M, Feneberg R, K\u00f6pf-Shakib S, T\u00f6nshoff B (2012) (Val-) Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation. Transpl Int 25:723\u2013731. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01485.x","journal-title":"Transpl Int"},{"key":"4790_CR85","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1128\/JVI.02487-09","volume":"84","author":"Q Meng","year":"2010","unstructured":"Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC (2010) The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol 84:4534\u20134542. https:\/\/doi.org\/10.1128\/JVI.02487-09","journal-title":"J Virol"},{"key":"4790_CR86","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/ajt.14020","volume":"17","author":"MA AlDabbagh","year":"2017","unstructured":"AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S (2017) The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review. Am J Transplant 17:770\u2013781. https:\/\/doi.org\/10.1111\/ajt.14020","journal-title":"Am J Transplant"},{"key":"4790_CR87","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A, The Transplantation Society International CMV Consensus Group (2018) The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102:900\u2013931. https:\/\/doi.org\/10.1097\/TP.0000000000002191","journal-title":"Transplantation"},{"key":"4790_CR88","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","volume":"5","author":"DP Funch","year":"2005","unstructured":"Funch DP, Walker AM, Schneider G, Ziyadeh NJ, Pescovitz MD (2005) Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 5:2894\u20132900. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01115.x","journal-title":"Am J Transplant"},{"key":"4790_CR89","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1097\/00007890-199812270-00006","volume":"66","author":"SV McDiarmid","year":"1998","unstructured":"McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, Mart\u00edn MG, Bahar R, Maxfield AL, Ament ME, Busuttil RW (1998) Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 66:1604\u20131611. https:\/\/doi.org\/10.1097\/00007890-199812270-00006","journal-title":"Transplantation"},{"key":"4790_CR90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2141.2011.08855.x","volume":"155","author":"A Worth","year":"2011","unstructured":"Worth A, Conyers R, Cohen J, Jagani M, Chiesa R, Rao K, Goulden N, Veys P, Amrolia PJ (2011) Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation. Br J Haematol 155:377\u2013385. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08855.x","journal-title":"Br J Haematol"},{"key":"4790_CR91","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1309\/AJCP9WYEXKOL9YUV","volume":"141","author":"Y-U Cho","year":"2014","unstructured":"Cho Y-U, Chi H-S, Jang S, Park SH, Park CJ (2014) Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders. Am J Clin Pathol 141:268\u2013274. https:\/\/doi.org\/10.1309\/AJCP9WYEXKOL9YUV","journal-title":"Am J Clin Pathol"},{"key":"4790_CR92","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10096-019-03508-z","volume":"38","author":"CF Baez","year":"2019","unstructured":"Baez CF, Gon\u00e7alves MTV, da Rocha WM, Magalh\u00e3es de Souza L, Savassi-Ribas F, de Oliveira Almeida NK, Delbue S, Guimar\u00e3es MAAM, Cavalcanti SMB, Luz FB, Varella RB (2019) Investigation of three oncogenic epitheliotropic viruses shows human papillomavirus in association with non-melanoma skin cancer. Eur J Clin Microbiol Infect Dis 38:1129\u20131133. https:\/\/doi.org\/10.1007\/s10096-019-03508-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4790_CR93","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jamadermatol.2018.1748","volume":"154","author":"AJ Nichols","year":"2018","unstructured":"Nichols AJ, Gonzalez A, Clark ES, Khan WN, Rosen AC, Guzman W, Rabinovitz H, Badiavas EV, Kirsner RS, Ioannides T (2018) Combined systemic and intratumoral administration of human papillomavirus vaccine to treat multiple cutaneous basaloid squamous cell carcinomas. JAMA Dermatol 154:927\u2013930. https:\/\/doi.org\/10.1001\/jamadermatol.2018.1748","journal-title":"JAMA Dermatol"},{"key":"4790_CR94","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.2215\/CJN.03320807","volume":"3","author":"G Wong","year":"2008","unstructured":"Wong G, Chapman JR, Craig JC (2008) Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol 3:S87\u2013S100. https:\/\/doi.org\/10.2215\/CJN.03320807","journal-title":"Clin J Am Soc Nephrol"},{"key":"4790_CR95","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/ndt\/gfq627","volume":"26","author":"G Wong","year":"2011","unstructured":"Wong G, Howard K, Webster AC, Chapman JR, Craig JC (2011) Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant 26:1729\u20131739. https:\/\/doi.org\/10.1093\/ndt\/gfq627","journal-title":"Nephrol Dial Transplant"},{"key":"4790_CR96","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2215\/CJN.03661106","volume":"2","author":"A Schwarz","year":"2007","unstructured":"Schwarz A, Vatandaslar S, Merkel S, Haller H (2007) Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2:750\u2013756. https:\/\/doi.org\/10.2215\/CJN.03661106","journal-title":"Clin J Am Soc Nephrol"},{"key":"4790_CR97","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/cncr.28043","volume":"119","author":"EC Hall","year":"2013","unstructured":"Hall EC, Pfeiffer RM, Segev DL, Engels EA (2013) Cumulative incidence of cancer after solid organ transplantation: Cancer Incidence After Transplantation. Cancer 119:2300\u20132308. https:\/\/doi.org\/10.1002\/cncr.28043","journal-title":"Cancer"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T03:58:09Z","timestamp":1634270289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04790-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}